Envoy Medical (COCH) Equity Ratio (2020 - 2026)

Envoy Medical has disclosed Equity Ratio across 7 years of filings, most recently posting 0.34 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.34, up 114.61% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.34 (up 114.61% YoY), and the FY2025 annual result was 1.42, up 13.01% from the prior year.
• Equity Ratio came in at 0.34 for Q1 2026 at Envoy Medical, up from 1.42 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.34 in Q1 2026 to a low of 14.16 in Q4 2022.
• The 5-year median for Equity Ratio is 1.0 (2023), against an average of 1.77.
• Across the five-year window, Equity Ratio slumped 13345.94% in 2022 and soared 477.81% in 2023, its largest moves.
• Envoy Medical's Equity Ratio stood at 14.16 in 2022, then surged by 98.48% to 0.21 in 2023, then tumbled by 660.52% to 1.63 in 2024, then advanced by 13.01% to 1.42 in 2025, then surged by 123.98% to 0.34 in 2026.
• The last three Equity Ratio figures came in at 0.34 (Q1 2026), 1.42 (Q4 2025), and 0.94 (Q3 2025), per Business Quant data.